Director, 10% Owner · Evommune, Inc. · Common Stock
Side
BUY
Value
$25.00M
Shares
1.56M
Price
$16
Executed
Nov 7, 2025
Disclosed
Nov 12, 2025
Disclosure timeline5 days from execution to publication · legal deadline 2 business days
Nov 7 executedNov 12, 2025 disclosed
EVMN · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 3 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering+5 / 15
1 other actor traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Verduyn-van Weegen Felice Isabel filed this Form 4 reporting a open-market purchase of EVMN on Nov 7, 2025. It became public on Nov 12, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, 10% Owner
Verduyn-van Weegen Felice Isabelcik:0002094941
Issuer
Evommune, Inc.cik:0002044725
Revision history · 0
No field has changed since this record was first ingested.
